Jisun Lee, Seo-Youn Choi, Jung Hoon Kim, Na Yeon Han, Mihyeon Park, Ho Sig Jang, Chan-Seop Kim, Seong Gyeong Ju, Ji Eun Moon, Ji Hye Min
{"title":"Determining malignant potential of pancreatic intraductal papillary mucinous neoplasm with CT: interobserver variability and diagnostic performance.","authors":"Jisun Lee, Seo-Youn Choi, Jung Hoon Kim, Na Yeon Han, Mihyeon Park, Ho Sig Jang, Chan-Seop Kim, Seong Gyeong Ju, Ji Eun Moon, Ji Hye Min","doi":"10.1007/s00261-026-05783-9","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>To evaluate interobserver agreement and diagnostic performance of computed tomography (CT) in assessing the malignant potential of pancreatic intraductal papillary mucinous neoplasms (IPMNs) based on the 2024 International evidence-based Kyoto guidelines, focusing on the impact of reviewer experience.</p><p><strong>Methods: </strong>In this multicenter retrospective study, CT images of 120 patients with pathologically confirmed IPMNs (53 malignant, 44.2%) were independently reviewed by eight observers (four experienced abdominal radiologists and four radiology residents). Malignant potential was graded using a five-point scale based on high-risk stigmata (HRS) and worrisome features (WF) defined by the 2024 Kyoto guidelines. Diagnostic performance (AUC) and interobserver agreement were compared between experience-based and guideline-based interpretations according to reviewer experience.</p><p><strong>Results: </strong>Among 120 patients (mean age, 65.9 ± 10.5 years; range, 41-87), 53 (44.2%) had malignant IPMNs. Interobserver agreement was substantial (α = 0.66) using the Kyoto guidelines and was higher among more experienced reviewers (α = 0.73 vs. 0.66; p < 0.001). Diagnostic performance was good (AUC, 0.75-0.89), with no statistically significant difference between more and less experienced reviewer groups (p = 0.26). For less experienced reviewers, guideline-based interpretation improved diagnostic performance (AUC 0.71-0.80 to 0.75-0.85; p < 0.001) and interobserver agreement (α = 0.43 to 0.66; p < 0.001) compared with experience-based assessment. In contrast, for more experienced reviewers, guideline-based interpretation did not result in a statistically significant change in diagnostic performance (AUC 0.88-0.92 to 0.82-0.89; p = 0.08), while interobserver agreement showed a modest decrease (α = 0.81 to 0.73; p < 0.001).</p><p><strong>Conclusion: </strong>The 2024 Kyoto guidelines demonstrated an experience-dependent effect, improving diagnostic performance and interobserver agreement among less experienced readers, with limited additional benefit for experienced radiologists.</p>","PeriodicalId":520541,"journal":{"name":"Abdominal radiology (New York)","volume":" ","pages":""},"PeriodicalIF":2.2000,"publicationDate":"2026-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Abdominal radiology (New York)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s00261-026-05783-9","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: To evaluate interobserver agreement and diagnostic performance of computed tomography (CT) in assessing the malignant potential of pancreatic intraductal papillary mucinous neoplasms (IPMNs) based on the 2024 International evidence-based Kyoto guidelines, focusing on the impact of reviewer experience.
Methods: In this multicenter retrospective study, CT images of 120 patients with pathologically confirmed IPMNs (53 malignant, 44.2%) were independently reviewed by eight observers (four experienced abdominal radiologists and four radiology residents). Malignant potential was graded using a five-point scale based on high-risk stigmata (HRS) and worrisome features (WF) defined by the 2024 Kyoto guidelines. Diagnostic performance (AUC) and interobserver agreement were compared between experience-based and guideline-based interpretations according to reviewer experience.
Results: Among 120 patients (mean age, 65.9 ± 10.5 years; range, 41-87), 53 (44.2%) had malignant IPMNs. Interobserver agreement was substantial (α = 0.66) using the Kyoto guidelines and was higher among more experienced reviewers (α = 0.73 vs. 0.66; p < 0.001). Diagnostic performance was good (AUC, 0.75-0.89), with no statistically significant difference between more and less experienced reviewer groups (p = 0.26). For less experienced reviewers, guideline-based interpretation improved diagnostic performance (AUC 0.71-0.80 to 0.75-0.85; p < 0.001) and interobserver agreement (α = 0.43 to 0.66; p < 0.001) compared with experience-based assessment. In contrast, for more experienced reviewers, guideline-based interpretation did not result in a statistically significant change in diagnostic performance (AUC 0.88-0.92 to 0.82-0.89; p = 0.08), while interobserver agreement showed a modest decrease (α = 0.81 to 0.73; p < 0.001).
Conclusion: The 2024 Kyoto guidelines demonstrated an experience-dependent effect, improving diagnostic performance and interobserver agreement among less experienced readers, with limited additional benefit for experienced radiologists.